Provexis PLC
NZCA
Company Profile
Business description
Provexis PLC is engaged in developing, licensing and selling the proprietary, scientific Fruitflow heart-health functional food ingredient for the global functional food sector. The extract is available in two formats, a syrup and a powder, and it can be included in a broad range of food, beverage and dietary supplement formats.
Contact
2 Blagrave Street
I Ford
ReadingBerkshireRG1 1AZ
GBRT: +44 7490391888
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
Stocks News & Analysis
stocks
Lithium’s latest drop and what it means for ASX investors
Volatility returns to the lithium market.
stocks
Major ASX miner remains overvalued following production update
Iron ore strength keeps production on track despite lower copper output.
stocks
Ahead of earnings, is Alphabet stock a buy, a sell, or fairly valued?
From Google Cloud to Gemini user retention, here’s what we expect from Alphabet’s earnings report.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,980.60 | 37.10 | 0.41% |
| CAC 40 | 8,340.11 | 1.30 | 0.02% |
| DAX 40 | 24,846.69 | 15.71 | 0.06% |
| Dow JONES (US) | 51,839.26 | 307.16 | -0.59% |
| FTSE 100 | 10,524.76 | 75.61 | -0.71% |
| HKSE | 25,150.75 | 7.70 | 0.03% |
| NASDAQ | 25,508.07 | 12.17 | -0.05% |
| Nikkei 225 | 65,740.43 | 1,599.31 | 2.49% |
| NZX 50 Index | 13,705.79 | 9.76 | 0.07% |
| S&P 500 | 7,443.28 | 14.41 | -0.19% |
| S&P/ASX 200 | 8,796.30 | 39.30 | 0.45% |
| SSE Composite Index | 3,819.66 | 23.37 | 0.62% |